Globeflex Capital’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.56M | Hold |
52,911
| – | – | 0.13% | 141 |
|
|
2025
Q1 | $1.58M | Hold |
52,911
| – | – | 0.15% | 127 |
|
|
2024
Q4 | $1.52M | Hold |
52,911
| – | – | 0.13% | 136 |
|
|
2024
Q3 | $2.04M | Sell |
52,911
-27
| -0.1% | -$1.04K | 0.2% | 114 |
|
|
2024
Q2 | $1.7M | Sell |
52,938
-7,132
| -12% | -$230K | 0.18% | 122 |
|
|
2024
Q1 | $2.33M | Buy |
60,070
+15,827
| +36% | +$614K | 0.23% | 111 |
|
|
2023
Q4 | $1.36M | Hold |
44,243
| – | – | 0.14% | 150 |
|
|
2023
Q3 | $989K | Sell |
44,243
-1,223
| -3% | -$27.3K | 0.12% | 174 |
|
|
2023
Q2 | $977K | Sell |
45,466
-1,783
| -4% | -$38.3K | 0.11% | 178 |
|
|
2023
Q1 | $1.13M | Hold |
47,249
| – | – | 0.14% | 167 |
|
|
2022
Q4 | $1.1M | Hold |
47,249
| – | – | 0.14% | 172 |
|
|
2022
Q3 | $757K | Hold |
47,249
| – | – | 0.13% | 203 |
|
|
2022
Q2 | $837K | Hold |
47,249
| – | – | 0.2% | 146 |
|
|
2022
Q1 | $962K | Hold |
47,249
| – | – | 0.2% | 147 |
|
|
2021
Q4 | $883K | Hold |
47,249
| – | – | 0.18% | 174 |
|
|
2021
Q3 | $933K | Hold |
47,249
| – | – | 0.2% | 158 |
|
|
2021
Q2 | $1.12M | Hold |
47,249
| – | – | 0.2% | 179 |
|
|
2021
Q1 | $1.12M | Sell |
47,249
-18,212
| -28% | -$432K | 0.2% | 168 |
|
|
2020
Q4 | $1.31M | Sell |
65,461
-35,668
| -35% | -$714K | 0.28% | 108 |
|
|
2020
Q3 | $2.11M | Buy |
101,129
+1,879
| +2% | +$39.1K | 0.56% | 30 |
|
|
2020
Q2 | $1.74M | Buy |
99,250
+944
| +1% | +$16.5K | 0.44% | 44 |
|
|
2020
Q1 | $1.61M | Buy |
98,306
+11,376
| +13% | +$186K | 0.49% | 36 |
|
|
2019
Q4 | $1.79M | Buy |
86,930
+1,854
| +2% | +$38.2K | 0.34% | 76 |
|
|
2019
Q3 | $977K | Hold |
85,076
| – | – | 0.21% | 158 |
|
|
2019
Q2 | $1.12M | Buy |
+85,076
| New | +$1.12M | 0.23% | 132 |
|